🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Status
Completed
Location
Knight Cancer Institute at Oregon Health and Science University
Start Date
2005-03
Trial ID
NCT00238433
Status - CLOSED TO PATIENT ENROLLMENT (CNPE) The study is being conducted ...
Status
Completed
Location
Houston Methodist Hospital
Start Date
2017-10-10
Trial ID
NCT03093350
Treatments Being Tested
This is a phase I single center dose escalation study with an extension at ...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-11-08
Trial ID
NCT01634217
Treatments Being Tested
The purpose of this study is to test the hypothesis that a pre-infusion pre...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2004-01
Trial ID
NCT00167180
Treatments Being Tested
Background: The National Cancer Institute (NCI) Surgery Branch has develop...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2014-02-07
Trial ID
NCT02111850
This is a first-in-human dose escalation/dose expansion study to evaluate t...
Status
Active Not Recruiting
Location
H Lee Moffitt Cancer Center and Research Institute
Start Date
2019-05-20
Trial ID
NCT03927261
Treatments Being Tested
The purposes of the study are to determine the maximum tolerated dose (MTD)...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2022-03-21
Trial ID
NCT05015426
Treatments Being Tested
Current treatments for relapsed/refractory hematopoietic malignancies such ...
Status
Unknown
Location
Multiple Locations
Start Date
2021-03
Trial ID
NCT04767308
Treatments Being Tested
This is a study to investigate the efficacy and safety of ADP-A2M4 in combi...
Status
Withdrawn
Location
Mayo Clinic Phoenix
Start Date
2020-07-02
Trial ID
NCT04408898
Treatments Being Tested
Chimeric antigen receptor (CAR)-modified T cells can mediate long-term dura...
Status
Unknown
Location
Sanbo Brain Hospital Capital Medical University
Start Date
2016-07
Trial ID
NCT02844062
Treatments Being Tested